Document Detail

Treatment of hypercalcemia.
MedLine Citation:
PMID:  6337798     Owner:  NLM     Status:  MEDLINE    
The indications, effectiveness, and adverse effects of the numerous treatment modalities for hypercalcemia are presented. Results of a retrospective chart review of 72 admissions (53 patients) for hypercalcemia-related diseases are presented to emphasize the therapeutic principles that should be applied in the management of these patients. Hydration, forced diuresis, oral phosphates, and glucocorticosteroid drugs are common therapeutic approaches. Combination therapy with glucocorticosteroid drugs, oral phosphates, and forced diuresis is utilized to take advantage of multiple mechanisms of action. Outpatient therapy for hypercalcemia consists primarily of glucocorticosteroid agents and oral phosphates. Most patients are treated if the serum calcium level is greater than or equal to 12 mg/dL. An algorithm is presented to assist the clinician in selecting the most efficacious treatment plan.
G T Elliott; M W McKenzie
Related Documents :
1760758 - Treatment of diarrhea of neonatal calves.
6459908 - Terminal half-lives in plasma and bioavailability of norethisterone, levonorgestrel, cy...
12114458 - Orthodontic facebows: safety issues and current management.
11829718 - Sublingual apomorphine for the treatment of erectile dysfunction.
19633548 - Novel treatment of medullary thyroid cancer.
10579078 - Recent perspectives in topical therapy in superficial bladder cancer.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Drug intelligence & clinical pharmacy     Volume:  17     ISSN:  0012-6578     ISO Abbreviation:  Drug Intell Clin Pharm     Publication Date:  1983 Jan 
Date Detail:
Created Date:  1983-04-07     Completed Date:  1983-04-07     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0212457     Medline TA:  Drug Intell Clin Pharm     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  12-22     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Calcium / blood
Chelating Agents / therapeutic use
Diuretics / therapeutic use
Hypercalcemia / drug therapy*,  etiology
Indomethacin / therapeutic use
Mineralocorticoids / therapeutic use
Phosphates / therapeutic use
Renal Dialysis
Serum Albumin / metabolism
Reg. No./Substance:
0/Chelating Agents; 0/Diuretics; 0/Mineralocorticoids; 0/Phosphates; 0/Serum Albumin; 53-86-1/Indomethacin; 7440-70-2/Calcium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Role of the liver in clearance and excretion of circulating carcinoembryonic antigen (CEA).
Next Document:  Slow-release oxprenolol compared with oxprenolol in hypertensive patients: a multicenter clinical tr...